Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP5-1052I5.2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | CLPSL2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | NCS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | C21orf58 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | NKX2-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | DGAT2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | AHDC1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | CEP162 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | CDK7 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |